Clinical Trial Update: Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study [Phase 2]

View source ↗

Summary

This is a Phase 2 randomized feasibility trial evaluating interferon-gamma as adjunctive therapy for chronic pulmonary aspergillosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Pulmonary Aspergillosis

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: Manchester University NHS Foundation Trust | Conditions: Chronic Pulmonary Aspergillosis, Aspergillosis | Phase 2 | Status: RECRUITING